Johnson & Johnson (NYSE: JNJ) reported a decline in adjusted profit for the third quarter of 2022, despite a modest increase in net
Johnson & Johnson
-(JNJ)
XNYS:JNJ
Johnson & Johnson (JNJ) offers long-term stability. Is the stock a buy?
Johnson & Johnson (NYSE: JNJ) has stayed largely unaffected by the COVID crisis and macroeconomic headwinds so far, which allowed the healthcare
Johnson & Johnson (JNJ) Q2 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joaquin Duato -- Chief
JNJ Earnings: Johnson & Johnson reports higher sales and adj. profit for Q2
Johnson & Johnson (NYSE: JNJ) reported an increase in sales and adjusted profit for the second quarter of 2022 when strong performance by
What awaits Johnson & Johnson (JNJ) beyond consumer business spinoff
Johnson & Johnson (NYSE: JNJ) is probably the most diversified healthcare firm that owns several popular consumer brands, which have brought both
Infographic: Highlights of Intuitive Surgical’s Q1 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in revenues, hurt
Kimberly-Clark (KMB) Q1 profit drops but beats estimates; revenue up 7%
Consumer products company Kimberly-Clark Corp. (NYSE: KMB) reported stronger-than-expected earnings and revenues for the first quarter of 2022. The company's stock made
Johnson & Johnson (JNJ) Q1 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2022 earnings call dated Apr. 19, 2022 Corporate Participants: Joseph J. Wolk -- Executive Vice President, Chief Financial
Johnson & Johnson (JNJ) reports Q1 2022 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Johnson & Johnson (JNJ) Q4 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2021 earnings call dated Jan. 25, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J. Wolk -- Executive
Johnson & Johnson (JNJ) reports Q4 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
IPO Alert: Here’s all you need to know about Bausch + Lomb’s market debut
After slowing down in the final weeks of 2021, IPO activity has picked up momentum despite the uncertain economic conditions. Eye care
Johnson & Johnson (JNJ) Q3 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2021 earnings call dated Oct. 19, 2021 Corporate Participants: Sarah Wood -- Senior Director, Investor Relations Joseph J.
Johnson & Johnson (JNJ) reports Q3 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Johnson & Johnson (JNJ) Q2 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice -- Vice President, Investor Relations Joseph J.
Johnson & Johnson (JNJ) Q2 2021 Earnings Call
Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice — Vice President, Investor Relations Joseph J. Wolk — Executive
Johnson & Johnson beats in Q2; raises FY guidance
Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant reported Q2
Earnings calendar for the week of July 19
Despite strong trading and encouraging news from the labor market, benchmark stock indexes pulled back after making modest gains early in the
Johnson & Johnson (JNJ) Q1 2021 Earnings Call
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Joseph J. Wolk — Executive Vice
Johnson & Johnson (JNJ) Q1 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations Joseph
Johnson & Johnson (JNJ) reports Q1 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue